PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7775602-6	1995	The number of melanosomes changed when agents which modulate the tyrosinase gene expression were added, since TPA decreased, dbcAMP increased, and linoleic acid or palmitic acid did not alter their number.	Bucladesine	125-131	tyrosinase	Mus musculus	65-75	
7686498-4	1993	Cholera toxin, alpha-melanocyte-stimulating hormone, and dibutyryl cyclic AMP increased tyrosinase activity and stimulated eumelanin biosynthesis.	Bucladesine	57-77	tyrosinase	Mus musculus	88-98	
2438034-7	1987	Dibutyryl cAMP and 3-isobutyl-1-methylxanthine augmented tyrosinase activation by PGE1 without enhancing the inhibitory action of PGE1 on cell growth.	Bucladesine	0-14	tyrosinase	Mus musculus	57-67	
2543086-3	1989	The abundance of tyrosinase message levels in melanoma cells treated with either MSH or dibutyryl cAMP was determined by Northern blot analysis utilizing a 946 base pair mouse tyrosinase cDNA probe.	Bucladesine	88-102	tyrosinase	Mus musculus	17-27	
2543086-3	1989	The abundance of tyrosinase message levels in melanoma cells treated with either MSH or dibutyryl cAMP was determined by Northern blot analysis utilizing a 946 base pair mouse tyrosinase cDNA probe.	Bucladesine	88-102	tyrosinase	Mus musculus	176-186	
6201140-5	1984	Melanotropin (melanocyte stimulating hormone), dibutyryl cyclic adenosine monophosphate, and isobutylmethylxanthine caused an increase in the abundance of newly synthesized tyrosinase that was directly proportional to the increase in enzyme activity.	Bucladesine	47-87	tyrosinase	Mus musculus	173-183